| Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib. | |
| | |
MedLine Citation:
|
PMID: 19951638 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Erlotinib is an epidermal growth factor receptor tyrosine kinase inhibitor that is responsible for several cutaneous side effects. We report a case of hand-foot syndrome associated with a papulo-pustular and seborrheic dermatitis-like eruption of the face in a 61-year-old patient treated with erlotinib for lung cancer. |
| | |
Authors:
|
Sophia Benomar; Saber Boutayeb; Yassir Afifi; Syrine Hamada; Jamila Bouhllab; Badreddine Hassam; Hassan Errihanni |
Related Documents
:
|
22307178 - Standardization of flow cytometry in myelodysplastic syndromes: a report from an intern... 6232098 - The baboon syndrome: systemically-induced allergic contact dermatitis. 20948068 - Glucagonoma syndrome. 6325068 - Migraine, tolosa-hunt syndrome and pleocytosis. correlation or coincidence? 16204418 - A school-based application of modified habit reversal for tourette syndrome via a trans... 12665418 - Novel therapies in the treatment of irritable bowel syndrome. |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2009-11-15 |
Journal Detail:
|
Title: Dermatology online journal Volume: 15 ISSN: 1087-2108 ISO Abbreviation: Dermatol. Online J. Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-12-02 Completed Date: 2010-02-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9610776 Medline TA: Dermatol Online J Country: United States |
Other Details:
|
Languages: eng Pagination: 2 Citation Subset: IM |
Affiliation:
|
Department of dermatology, Ibn Sina Hospital, Mohamed V University of Rabat, Morocco. sophiabenomar@yahoo.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carcinoma, Non-Small-Cell Lung
/
drug therapy,
pathology,
surgery Chemotherapy, Adjuvant Dermatitis, Seborrheic / chemically induced*, physiopathology Disease Progression Drug Eruptions / etiology*, physiopathology Facial Dermatoses / chemically induced, physiopathology Follow-Up Studies Hand Dermatoses / chemically induced, physiopathology Humans Lung Neoplasms / drug therapy, pathology, surgery Male Middle Aged Protein Kinase Inhibitors / adverse effects*, therapeutic use Quinazolines / adverse effects*, therapeutic use Risk Assessment Syndrome |
| Chemical | |
Reg. No./Substance:
|
0/Protein Kinase Inhibitors; 0/Quinazolines; 0/erlotinib |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Melanoma costs: A dynamic model comparing estimated overall costs of various clinical stages.
Next Document: Linear IgA bullous dermatosis following influenza vaccination.